LLC,LL/2(LLC1)

Export PDF

Strain Information

Cell Line

LLC,LL/2(LLC1)

Cat. NO.

NM-S30A

Model Description

LLC is a murine cell line of Lewis lung carcinoma, established from a tumor on the lung of a C57BL mouse following an implantation of primary Lewis lung carcinoma.

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. Morphology of LLC cell line.

Aimage.png

Bimage.png

Cimage.png

Fig2. Analysis of Tumorigenesis in C57BL/6 mice（n=4）. (A) Tumor volume, (B) body weight, and (C) survival ratio was checked by time.

*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more